MA41150B1 - Polymères de liaison aux protons pour administration orale - Google Patents
Polymères de liaison aux protons pour administration oraleInfo
- Publication number
- MA41150B1 MA41150B1 MA41150A MA41150A MA41150B1 MA 41150 B1 MA41150 B1 MA 41150B1 MA 41150 A MA41150 A MA 41150A MA 41150 A MA41150 A MA 41150A MA 41150 B1 MA41150 B1 MA 41150B1
- Authority
- MA
- Morocco
- Prior art keywords
- proton
- oral administration
- binding polymers
- methods
- pharmaceutical compositions
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000010606 normalization Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/02—Alkylation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
- C08F226/04—Diallylamine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F26/02—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F26/02—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
- C08F26/04—Diallylamine
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F271/00—Macromolecular compounds obtained by polymerising monomers on to polymers of nitrogen-containing monomers as defined in group C08F26/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2810/00—Chemical modification of a polymer
- C08F2810/20—Chemical modification of a polymer leading to a crosslinking, either explicitly or inherently
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
- C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne des compositions pharmaceutiques et des méthodes pour le traitement d'un animal, y compris un être humain, ainsi que des méthodes de préparation de ces compositions. Lesdites compositions pharmaceutiques contiennent des polymères aminés réticulés et peuvent être utilisées, par exemple, pour traiter des maladies et d'autres affections métaboliques dans lesquelles l'élimination de protons et/ou d'ions chlorure du tractus gastro-intestinal est susceptible d'apporter des bénéfices physiologiques, comme la normalisation des concentrations sériques de bicarbonate et du ph sanguin chez un animal, y compris un être humain.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462090287P | 2014-12-10 | 2014-12-10 | |
PCT/US2015/065041 WO2016094685A1 (fr) | 2014-12-10 | 2015-12-10 | Polymères de liaison aux protons pour administration orale |
Publications (2)
Publication Number | Publication Date |
---|---|
MA41150A MA41150A (fr) | 2017-10-18 |
MA41150B1 true MA41150B1 (fr) | 2020-06-30 |
Family
ID=55080167
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA41150A MA41150B1 (fr) | 2014-12-10 | 2015-12-10 | Polymères de liaison aux protons pour administration orale |
MA48486A MA48486B1 (fr) | 2014-12-10 | 2015-12-10 | Polymères liant les protons pour administration orale |
MA053106A MA53106A (fr) | 2014-12-10 | 2015-12-10 | Polymères liant les protons pour administration orale |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA48486A MA48486B1 (fr) | 2014-12-10 | 2015-12-10 | Polymères liant les protons pour administration orale |
MA053106A MA53106A (fr) | 2014-12-10 | 2015-12-10 | Polymères liant les protons pour administration orale |
Country Status (26)
Country | Link |
---|---|
US (3) | US11311571B2 (fr) |
EP (3) | EP3718551A1 (fr) |
JP (4) | JP6903576B2 (fr) |
KR (2) | KR102625115B1 (fr) |
CN (2) | CN113855703A (fr) |
AU (2) | AU2015360413B2 (fr) |
BR (2) | BR122021001914B1 (fr) |
CA (3) | CA2969238C (fr) |
CY (2) | CY1122928T1 (fr) |
DK (2) | DK3593808T3 (fr) |
ES (2) | ES2857177T3 (fr) |
HK (1) | HK1243952A1 (fr) |
HR (2) | HRP20200689T1 (fr) |
HU (2) | HUE049057T2 (fr) |
IL (3) | IL252439B (fr) |
LT (2) | LT3593808T (fr) |
MA (3) | MA41150B1 (fr) |
MD (2) | MD3593808T2 (fr) |
ME (1) | ME03783B (fr) |
MX (3) | MX2017007497A (fr) |
PL (2) | PL3593808T3 (fr) |
PT (2) | PT3593808T (fr) |
RS (2) | RS60208B1 (fr) |
RU (2) | RU2020102937A (fr) |
SI (2) | SI3593808T1 (fr) |
WO (1) | WO2016094685A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3578185B1 (fr) | 2013-06-05 | 2020-08-05 | Tricida Inc. | Polymères liant les protons pour administration orale |
BR122021001914B1 (pt) | 2014-12-10 | 2024-02-27 | Tricida, Inc | Processo para preparação de um polímero de amina reticulada |
US11406661B2 (en) | 2016-05-06 | 2022-08-09 | Tricida, Inc. | HCl-binding compositions for and methods of treating acid-base disorders |
AU2017388956A1 (en) | 2016-12-28 | 2019-07-11 | Fujifilm Corporation | Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles |
US10934380B1 (en) | 2017-09-25 | 2021-03-02 | Tricida, Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
WO2019078197A1 (fr) | 2017-10-16 | 2019-04-25 | 富士フイルム株式会社 | Agent thérapeutique contre l'hyperphosphatémie |
EP3703706A4 (fr) | 2017-11-03 | 2022-04-27 | Tricida Inc. | Compositions et méthode pour traiter des troubles acide-base |
EP3740201A4 (fr) * | 2018-06-04 | 2021-03-17 | Tricida Inc. | Méthode de traitement de troubles de l'équilibre acido-basique |
WO2019236124A1 (fr) * | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Méthode de traitement de troubles de l'équilibre acido-basique |
EP4053179A1 (fr) | 2021-03-01 | 2022-09-07 | Tricida Inc. | Compositions pharmaceutiques à base de polymères réticulés de poly(allylamine) |
Family Cites Families (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01100164A (ja) * | 1987-10-12 | 1989-04-18 | Shionogi & Co Ltd | スルファモイル−2−ベンゾフランカルボン酸誘導体 |
US6444221B1 (en) | 1992-06-30 | 2002-09-03 | Howard K. Shapiro | Methods of treating chronic inflammatory diseases using carbonyl trapping agents |
US20050090553A1 (en) | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
US5556619A (en) * | 1992-08-20 | 1996-09-17 | The Du Pont Merck Pharmaceutical Company | Crosslinked polymeric ammonium salts |
US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5648355A (en) | 1994-02-09 | 1997-07-15 | Kos Pharmaceutical, Inc. | Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
AU703842B2 (en) | 1994-10-17 | 1999-04-01 | Robert M. Bersin | Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders |
US20020006899A1 (en) | 1998-10-06 | 2002-01-17 | Pospisilik Andrew J. | Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
US5753706A (en) | 1996-12-16 | 1998-05-19 | Hsu; Chen Hsing | Methods for treating renal failure |
JP3952223B2 (ja) * | 1997-05-28 | 2007-08-01 | 日東紡績株式会社 | アリルアミン重合体 |
AUPO758297A0 (en) | 1997-06-27 | 1997-07-24 | Rowe, James Baber | Control of acidic gut syndrome |
US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
AU2682499A (en) | 1998-02-17 | 1999-08-30 | Dimitri R. Kioussis | Anion binding polymers and the use thereof |
US6485703B1 (en) | 1998-07-31 | 2002-11-26 | The Texas A&M University System | Compositions and methods for analyte detection |
US6271264B1 (en) | 1998-12-01 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
GB9927088D0 (en) | 1999-11-17 | 2000-01-12 | Secr Defence | Use of poly(diallylamine) polymers |
US20040059065A1 (en) | 2000-03-09 | 2004-03-25 | Takeshi Goto | Crosslinked anion-exchange resin or salt thereof |
WO2001066607A1 (fr) | 2000-03-09 | 2001-09-13 | Hisamitsu Pharmaceutical Co., Inc. | Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant |
US20030091530A1 (en) | 2000-03-13 | 2003-05-15 | Takeshi Goto | Preventives and/or remedies for hyperphosphatemia |
JP2002028737A (ja) | 2000-07-07 | 2002-01-29 | Fujitsu Ltd | プレス打ち抜き加工方法及びプレス打ち抜き加工装置 |
AU2002252632B2 (en) | 2001-04-18 | 2004-09-23 | Genzyme Corporation | Low salt forms of polyallylamine |
JP2004528332A (ja) | 2001-04-18 | 2004-09-16 | ジェンザイム コーポレーション | 痛風を治療する方法および尿酸を結合する方法 |
TW200304813A (en) | 2002-03-11 | 2003-10-16 | Novartis Ag | Salts of organic acid |
US20070135335A1 (en) | 2003-02-10 | 2007-06-14 | Autogen Research Pty Ltd. | Therapeutic molecules |
TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
US7767768B2 (en) | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
US7608674B2 (en) * | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7385012B2 (en) | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US7459502B2 (en) | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
US7449605B2 (en) | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
EP1699442A2 (fr) | 2003-12-31 | 2006-09-13 | Genzyme Corporation | Agents sequestrants des acides biliaires a base de polymeres d'amine aliphatique a revetement gastro-resistant |
CN1905901A (zh) | 2004-01-29 | 2007-01-31 | 学校法人庆应义塾 | 红细胞功能修饰物质 |
CA2557848C (fr) | 2004-03-30 | 2013-12-10 | Ilypsa, Inc. | Compositions pour liaison ionique |
US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
US7429394B2 (en) | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US8399025B2 (en) | 2004-06-04 | 2013-03-19 | Board Of Regents, The University Of Texas System | Polyamine modified particles |
CN101022821B (zh) | 2004-07-19 | 2014-01-29 | 纽崔西亚公司 | 天冬氨酸用于调节血中葡萄糖水平的用途 |
DE102004035808A1 (de) | 2004-07-21 | 2006-03-16 | Kasch, Helmut, Dr. | Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen |
US8569277B2 (en) | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
US20070293429A1 (en) | 2004-10-08 | 2007-12-20 | Therapei Pharmaceuticals, Inc. | Vasoactive Intestinal Polypeptide Compositions |
US20080214440A1 (en) | 2004-10-08 | 2008-09-04 | Forbes Medi-Tech (Research), Inc. | Vasoactive intestinal polypeptide compositions |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
ITME20040015A1 (it) | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
CA2613875C (fr) | 2005-07-04 | 2018-09-25 | Ramu Krishnan | Medicament ou composes pharmaceutiques ameliores et preparation associee |
MX354649B (es) | 2005-08-18 | 2018-03-14 | Panion & Bf Biotech Inc | Compuestos organicos ferricos grado farmaceutico, uso de los mismos y metodos para elaborar los mismos. |
WO2007027566A2 (fr) | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Recepteurs moleculaires polymeriques utilises comme sequestrants du phosphate |
CA2624112A1 (fr) | 2005-09-30 | 2007-04-05 | Ilypsa, Inc. | Procedes pour preparer des composites coeur-ecorce qui presentent des ecorces reticulees et composites coeur-ecorce ainsi prepares |
BRPI0616604A2 (pt) | 2005-09-30 | 2012-12-25 | Ilypsa Inc | mÉtodo para remover e composiÇço para seletivamente remover Íon de potÁssio do trato gastrintestinal de um mamÍfero, mÉtodo para seletivamente remover Íon de potÁssio de um meio-ambiente, composiÇço farmacÊutica, partÍcula de nécleo-envoltàrio, e, usos de uma partÍcula de nécleo-envoltàrio e de uma composiÇço farmacÊutica |
WO2007038801A2 (fr) | 2005-09-30 | 2007-04-05 | Ilypsa, Inc. | Compositions de liaison aux cations monovalents comprenant des particules coeur-ecorce avec des ecorces polyvinyliques reticulees et procedes pour les utiliser |
WO2007055044A1 (fr) | 2005-11-08 | 2007-05-18 | Ajinomoto Co., Inc. | Agent facilitant le reveil apres une anesthesie |
JP2009514966A (ja) | 2005-11-08 | 2009-04-09 | ジェンザイム・コーポレーション | 高リン血症のためのマグネシウム含有重合体 |
ITMI20052461A1 (it) | 2005-12-22 | 2007-06-23 | Univ Degli Studi Milano | Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive |
RU2008136081A (ru) | 2006-02-14 | 2010-03-20 | Тева Фармасьютикл Индастриес Лтд. (Il) | Фармацевтические составы с алифатическими аминными полимерами и способы их производства |
EP2016114A2 (fr) | 2006-05-05 | 2009-01-21 | Genzyme Corporation | Polymères de condensation d'amines comme agents séquestrants de phosphates |
WO2008005217A2 (fr) | 2006-07-05 | 2008-01-10 | Genzyme Corporation | Traitements contenant du fer(ii) pour l'hyperphosphatémie |
EP2049014A2 (fr) | 2006-07-18 | 2009-04-22 | Genzyme Corporation | Dendrimères aminiques |
AU2007281433A1 (en) | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Compositions for intranasal delivery of human insulin and uses thereof |
WO2008027551A2 (fr) | 2006-09-01 | 2008-03-06 | Genzyme Corporation | Compositions de dendrimères |
US7964182B2 (en) | 2006-09-01 | 2011-06-21 | USV, Ltd | Pharmaceutical compositions comprising phosphate-binding polymer |
BRPI0717008A2 (pt) | 2006-09-01 | 2014-01-21 | Usv Ltd | Processo para o preparo de cloridrato de sevelamer e formulação do mesmo |
JP5427029B2 (ja) | 2006-09-06 | 2014-02-26 | スキャンポ・アーゲー | 消化管の重炭酸分泌を促進するための方法および組成物 |
JP2010504975A (ja) | 2006-09-29 | 2010-02-18 | ゲンズイメ コーポレーション | アミドデンドリマー組成物 |
BRPI0720234A2 (pt) | 2006-12-14 | 2013-12-24 | Genzyme Corp | Composição farmacêutica |
WO2008103368A1 (fr) | 2007-02-23 | 2008-08-28 | Genzyme Corporation | Compositions de polymère amine |
US20080207766A1 (en) | 2007-02-27 | 2008-08-28 | Agi Therapeutics Research Ltd. | Methods and compositions for treating at least one upper gastrointestinal symptom |
JP2010520285A (ja) | 2007-03-08 | 2010-06-10 | ゲンズイメ コーポレーション | スルホンポリマー組成物 |
TWI445540B (zh) | 2007-04-20 | 2014-07-21 | Ajinomoto Kk | 抗低體溫組成物 |
EP2152277A1 (fr) | 2007-04-27 | 2010-02-17 | Genzyme Corporation | Compositions dendrimères amido-amine |
US8273384B2 (en) | 2007-07-02 | 2012-09-25 | Stephen Ray Wurzberger | Process for the preparation of a non-corrosive base solution and methods of using same |
JPWO2009008480A1 (ja) * | 2007-07-11 | 2010-09-09 | 東レ株式会社 | 架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途 |
EP2016947A1 (fr) | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Nouveau processus à une étape pour préparer des polymères poly(allylamine) réticulés |
WO2009023544A2 (fr) | 2007-08-10 | 2009-02-19 | Ilypsa, Inc. | Compositions pharmaceutiques à base de polymères échangeurs d'anions en dose |
US20090125433A1 (en) * | 2007-11-13 | 2009-05-14 | Franck Rene Mikulecz | Best pre-match routing (of foreign exchange orders) |
US20090156647A1 (en) | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Method for maintaining physiological pH levels during intensive physical exercise |
PA8807201A1 (es) | 2007-12-14 | 2009-07-23 | Genzyme Corp | Composiciones farmaceuticas |
WO2009078958A1 (fr) | 2007-12-14 | 2009-06-25 | Genzyme Corporation | Compositions pharmaceutiques enrobées |
WO2009097127A1 (fr) | 2008-01-31 | 2009-08-06 | Genzyme Corporation | Compositions pharmaceutiques |
JP2009179724A (ja) * | 2008-01-31 | 2009-08-13 | Toray Ind Inc | 架橋ポリビニルアミン又はその酸付加塩、及びその医薬用途 |
EA201071059A1 (ru) | 2008-03-11 | 2011-04-29 | Лайвайонекс Инк. | Способы и композиции для лечения воспаления и связанных с воспалением патологических состояний |
WO2009125433A2 (fr) * | 2008-04-08 | 2009-10-15 | Usv Limited | Procédé pour la fabrication d'un sel de polymère d'amine |
WO2009125443A1 (fr) | 2008-04-11 | 2009-10-15 | General Project S.R.L. | Pièce à main pour le traitement aux ultrasons de tissu humain |
US20110142952A1 (en) | 2008-06-20 | 2011-06-16 | Harris David J | Pharmaceutical Compositions |
DE102008030046A1 (de) | 2008-06-25 | 2009-12-31 | Ratiopharm Gmbh | Kompaktiertes Polyallylamin-Polymer |
US20100008988A1 (en) | 2008-07-14 | 2010-01-14 | Glenmark Generics, Ltd. | Tablet compositions of amine polymers |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
WO2010022380A2 (fr) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Compositions de polyfluoroacrylate stabilisé par polyol linéaire |
WO2010022381A1 (fr) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Traitement d'une hyperkaliémie par des polymères d'échange de cation réticulés ayant des propriétés physiques améliorées |
AU2009295586B2 (en) | 2008-09-25 | 2014-01-09 | Vive Nano, Inc. | Methods to produce polymer nanoparticles and formulations of active ingredients |
US20110268666A1 (en) | 2008-09-29 | 2011-11-03 | Yissum Research Development Company of the Research University of Jerusalem, Ltd. | Novel gastroretentive delivery system |
WO2010059384A1 (fr) | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Procédé de préparation de dérivés de pyridine tri-substituée et de pyrimidine tri-substituée utiles comme agonistes du récepteur du peptide insulinotrope glucose-dépendant |
US20100166861A1 (en) | 2008-12-29 | 2010-07-01 | Kelly Noel Lynch | Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone |
CA2749397A1 (fr) | 2009-01-22 | 2010-08-05 | Usv Limited | Compositions pharmaceutiques comprenant un polymere liant le phosphate |
WO2011059609A2 (fr) | 2009-10-13 | 2011-05-19 | The Regents Of The University Of Michigan | Compositions de dendrimères et procédés de synthèse |
EA024699B1 (ru) | 2009-10-22 | 2016-10-31 | Синтон Б. В. | Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат |
JP5984675B2 (ja) | 2009-12-07 | 2016-09-06 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | 胃腸障害の療法 |
US9181364B2 (en) | 2010-02-24 | 2015-11-10 | Relypsa, Inc. | Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants |
WO2011106545A1 (fr) | 2010-02-24 | 2011-09-01 | Relypsa, Inc. | Polyimidazoles pour emploi en tant qu'agents séquestrants d'acide biliaire |
IT1406068B1 (it) | 2010-07-22 | 2014-02-06 | Medestea Int Spa | Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego |
WO2012027331A1 (fr) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés |
KR101238210B1 (ko) | 2011-06-30 | 2013-03-04 | 엘지전자 주식회사 | 이동 단말기 |
US20130137772A1 (en) | 2011-11-29 | 2013-05-30 | Raymond J. Bergeron | Hydroxypolyamine salts |
PL3730136T3 (pl) | 2012-06-21 | 2024-03-25 | Keryx Biopharmaceuticals, Inc. | Zastosowanie cytrynianu żelaza(iii) w leczeniu pacjentów z przewlekłą chorobą nerek |
KR20150088243A (ko) | 2012-10-08 | 2015-07-31 | 리립사, 인크. | 고혈압 및 고칼륨혈증을 치료하기 위한 칼륨-결합제 |
EP3578185B1 (fr) | 2013-06-05 | 2020-08-05 | Tricida Inc. | Polymères liant les protons pour administration orale |
JP2016535780A (ja) | 2013-11-04 | 2016-11-17 | ケリク バイオファーマシューティカルス, インコーポレーテッド | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
BR122021001914B1 (pt) | 2014-12-10 | 2024-02-27 | Tricida, Inc | Processo para preparação de um polímero de amina reticulada |
US11406661B2 (en) | 2016-05-06 | 2022-08-09 | Tricida, Inc. | HCl-binding compositions for and methods of treating acid-base disorders |
US10934380B1 (en) | 2017-09-25 | 2021-03-02 | Tricida, Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
AU2018360868A1 (en) | 2017-11-03 | 2020-04-30 | Tricida, Inc. | Method of treating acid-base disorders |
EP3703706A4 (fr) | 2017-11-03 | 2022-04-27 | Tricida Inc. | Compositions et méthode pour traiter des troubles acide-base |
WO2019236124A1 (fr) | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Méthode de traitement de troubles de l'équilibre acido-basique |
WO2019236639A1 (fr) | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Méthode de traitement des troubles de l'équilibre acido-basique |
EP3740201A4 (fr) | 2018-06-04 | 2021-03-17 | Tricida Inc. | Méthode de traitement de troubles de l'équilibre acido-basique |
US20200306209A1 (en) | 2019-03-27 | 2020-10-01 | Tricida, Inc. | Method of treating acid-base disorders |
-
2015
- 2015-12-10 BR BR122021001914-2A patent/BR122021001914B1/pt active IP Right Grant
- 2015-12-10 WO PCT/US2015/065041 patent/WO2016094685A1/fr active Application Filing
- 2015-12-10 RS RS20200504A patent/RS60208B1/sr unknown
- 2015-12-10 MD MDE20200240T patent/MD3593808T2/ro unknown
- 2015-12-10 CA CA2969238A patent/CA2969238C/fr active Active
- 2015-12-10 HU HUE15823049A patent/HUE049057T2/hu unknown
- 2015-12-10 KR KR1020177018413A patent/KR102625115B1/ko active IP Right Grant
- 2015-12-10 PT PT191913961T patent/PT3593808T/pt unknown
- 2015-12-10 CN CN202111132616.0A patent/CN113855703A/zh active Pending
- 2015-12-10 EP EP20154562.1A patent/EP3718551A1/fr active Pending
- 2015-12-10 MA MA41150A patent/MA41150B1/fr unknown
- 2015-12-10 MA MA48486A patent/MA48486B1/fr unknown
- 2015-12-10 ES ES19191396T patent/ES2857177T3/es active Active
- 2015-12-10 AU AU2015360413A patent/AU2015360413B2/en active Active
- 2015-12-10 US US15/533,705 patent/US11311571B2/en active Active
- 2015-12-10 CA CA3164664A patent/CA3164664A1/fr active Pending
- 2015-12-10 ME MEP-2020-85A patent/ME03783B/fr unknown
- 2015-12-10 KR KR1020247000875A patent/KR20240008418A/ko active Application Filing
- 2015-12-10 SI SI201531470T patent/SI3593808T1/sl unknown
- 2015-12-10 ES ES15823049T patent/ES2787218T3/es active Active
- 2015-12-10 CA CA3205149A patent/CA3205149A1/fr active Pending
- 2015-12-10 RS RS20210136A patent/RS61409B1/sr unknown
- 2015-12-10 PL PL19191396T patent/PL3593808T3/pl unknown
- 2015-12-10 MA MA053106A patent/MA53106A/fr unknown
- 2015-12-10 JP JP2017531176A patent/JP6903576B2/ja active Active
- 2015-12-10 DK DK19191396.1T patent/DK3593808T3/da active
- 2015-12-10 DK DK15823049.0T patent/DK3229816T3/da active
- 2015-12-10 PT PT158230490T patent/PT3229816T/pt unknown
- 2015-12-10 RU RU2020102937A patent/RU2020102937A/ru unknown
- 2015-12-10 BR BR112017011838-6A patent/BR112017011838B1/pt active IP Right Grant
- 2015-12-10 LT LTEP19191396.1T patent/LT3593808T/lt unknown
- 2015-12-10 RU RU2017124157A patent/RU2713416C2/ru active
- 2015-12-10 PL PL15823049T patent/PL3229816T3/pl unknown
- 2015-12-10 MX MX2017007497A patent/MX2017007497A/es active IP Right Grant
- 2015-12-10 EP EP15823049.0A patent/EP3229816B1/fr active Active
- 2015-12-10 SI SI201531167T patent/SI3229816T1/sl unknown
- 2015-12-10 CN CN201580075741.9A patent/CN107428955B/zh active Active
- 2015-12-10 EP EP19191396.1A patent/EP3593808B1/fr active Active
- 2015-12-10 HU HUE19191396A patent/HUE052736T2/hu unknown
- 2015-12-10 MD MDE20170179T patent/MD3229816T2/ro unknown
- 2015-12-10 LT LTEP15823049.0T patent/LT3229816T/lt unknown
-
2017
- 2017-05-22 IL IL252439A patent/IL252439B/en active IP Right Grant
- 2017-06-08 MX MX2019014711A patent/MX2019014711A/es unknown
- 2017-06-08 MX MX2021004558A patent/MX2021004558A/es unknown
-
2018
- 2018-03-14 HK HK18103560.4A patent/HK1243952A1/zh unknown
-
2020
- 2020-04-29 HR HRP20200689TT patent/HRP20200689T1/hr unknown
- 2020-04-30 CY CY20201100400T patent/CY1122928T1/el unknown
- 2020-06-18 JP JP2020104945A patent/JP6921276B2/ja active Active
- 2020-10-13 IL IL278034A patent/IL278034B/en unknown
-
2021
- 2021-02-05 HR HRP20210204TT patent/HRP20210204T1/hr unknown
- 2021-02-19 CY CY20211100141T patent/CY1124073T1/el unknown
- 2021-07-27 JP JP2021122260A patent/JP7258087B2/ja active Active
- 2021-10-06 AU AU2021245144A patent/AU2021245144B2/en active Active
-
2022
- 2022-02-20 IL IL290729A patent/IL290729A/en unknown
- 2022-04-19 US US17/724,105 patent/US11738041B2/en active Active
-
2023
- 2023-04-04 JP JP2023060573A patent/JP2023085428A/ja active Pending
- 2023-08-28 US US18/238,665 patent/US20230405043A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA41150B1 (fr) | Polymères de liaison aux protons pour administration orale | |
MY197091A (en) | Compositions for treating acid-base disorders | |
MX2021013880A (es) | Polimeros enlazados al proton para administracion oral. | |
MA39033A1 (fr) | Formes solides d'acide {[5-(3-chlorophényl)-3-hydroxypyridine-2-carbonyl] amino}acétique, compositions et leurs utilisations | |
MY173699A (en) | Novel compounds for the treatment of diseases associated with amyloid of amyloid-like proteins | |
MA31845B1 (fr) | Pipéridino-dihydrothiénopyrimidines substituées | |
MA33734B1 (fr) | N1-pyrazolospirocétone inhibitrices d'acétyl-coa carboxylase | |
MA33467B1 (fr) | Promédicaments comprenant un conjugué insuline-lieur | |
MX2017003066A (es) | Composiciones farmaceuticas que comprenden un compuesto de dextrometorfano y quinidina para el tratamiento de agitacion en demencia. | |
CN107406464A8 (zh) | 精氨酸酶抑制剂及其治疗用途 | |
FI3347002T3 (fi) | Alzheimerin taudin hoitaminen tietyssä potilaspopulaatiossa | |
EA200802398A1 (ru) | Гранулы липоевой кислоты | |
EA201170117A1 (ru) | Противоаллергические биополимеры морского происхождения | |
BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
MA39447B1 (fr) | Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
BR102016012501A2 (pt) | peptídeo, composição farmacêutica, uso do peptídeo, e, uso da composição farmacêutica | |
MA39448B1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
UA109359C2 (xx) | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
RU2353358C2 (ru) | Производные прегабалина для лечения приливов | |
AR109760A1 (es) | Composiciones y métodos para tratar el mal de alzheimer y la enfermedad de parkinson | |
UA111587C2 (uk) | Сполуки для лікування захворювань, пов'язаних з амілоїдними або амілоїдоподібними білками | |
PH12020551900A1 (en) | Novel compound exhibiting enteropeptidase inhibitory activity | |
RU2018110031A (ru) | Способ лечения и профилактика гриппа | |
MA39446A1 (fr) | Compositions pharmaceutiques pour traiter des maladies infecteuses | |
MA37957A1 (fr) | Procédés de traitement de la maladie d'alzheimer et compositions pharmaceutiques associées |